Zhengye Biotechnology Holding Restricted (ZYBT) plans to lift $7 million in an preliminary public providing (IPO) on the week of September thirtieth, IPO Scoop studies. The corporate might be issuing 1,500,000 shares at $4.00-$5.00 per share.
Within the final twelve months, Zhengye Biotechnology Holding Restricted generated $29.8 million in income and $4.4 million in internet earnings. Zhengye Biotechnology Holding Restricted has a market cap of $211 million.
Kingswood Capital Markets acted because the underwriter for the IPO.
Zhengye Biotechnology Holding Restricted supplied the next description of their firm for its IPO: “We’re a holding firm integrated within the Cayman Islands. Our underlying enterprise is a Chinese language firm that makes and distributes vaccines for livestock. (Integrated within the Cayman Islands) We, via the working entity, give attention to the analysis, improvement, manufacturing and gross sales of veterinary vaccines, with an emphasis on vaccines for livestock. For almost 20 years, the working entity has been dedicated to enhancing the well being of livestock. The working entity markets a various vary of vaccines, together with vaccines for swine, cattle, goats, sheep, poultry and canine. The working entity’s merchandise can be found in 29 provincial areas throughout China and are exported abroad to Vietnam, Pakistan and Egypt. *Word: Internet earnings and income are in U.S. {dollars} (transformed from China’s forex) for the 12 months that ended Dec. 31, 2023. (Word: Zhengye Biotechnology Holding says Kingswood Capital Markets has been named the brand new sole book-runner, changing US Tiger Securities.) (Word: Zhengye Biotechnology Holding Restricted elevated its IPO’s measurement to 1.5 million shares – up from 1.25 million shares initially – at a worth vary of $4.00 to $5.00 – to lift $6.75 million, in accordance with an F-1/A submitting dated Aug. 22, 2024. Background: Zhengye Biotechnology Holding filed its F-1 on Jan. 9, 2024, with out disclosing phrases for its IPO. The corporate submitted its confidential IPO paperwork to the SEC in August 2023.) “.
Zhengye Biotechnology Holding Restricted was based in 2004 and has 299 workers. The corporate is positioned at No.1 Lianmeng Street, Jilin Financial & Technical Growth Zone Jilin Metropolis, Jilin Province, China and could be reached through cellphone at +86-0432-63047008 or on the internet at http://www.jlzybio.com/.
Obtain Information & Scores for Zhengye Biotechnology Holding Restricted Each day – Enter your e-mail deal with beneath to obtain a concise every day abstract of the newest information and analysts’ scores for Zhengye Biotechnology Holding Restricted and associated corporations with MarketBeat.com’s FREE every day e-mail publication.